Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 232,738
  • Shares Outstanding, K 66,687
  • Annual Sales, $ 65,170 K
  • Annual Income, $ -62,490 K
  • EBIT $ -64 M
  • EBITDA $ -55 M
  • 60-Month Beta 1.00
  • Price/Sales 3.84
  • Price/Cash Flow N/A
  • Price/Book 2.92

Options Overview Details

View History
  • Implied Volatility 115.28% ( -20.23%)
  • Historical Volatility 65.27%
  • IV Percentile 18%
  • IV Rank 8.32%
  • IV High 674.61% on 04/04/25
  • IV Low 64.51% on 08/16/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 2
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 304
  • Open Int (30-Day) 329

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +434,447.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.59 +34.75%
on 06/20/25
3.79 -7.92%
on 07/10/25
+0.49 (+16.33%)
since 06/11/25
3-Month
2.58 +35.27%
on 04/21/25
3.79 -7.92%
on 07/10/25
+0.61 (+21.18%)
since 04/11/25
52-Week
2.58 +35.27%
on 04/21/25
4.92 -29.07%
on 02/19/25
-1.22 (-25.90%)
since 07/11/24

Most Recent Stories

More News
Regulatory Breakthroughs and New Technologies Drive Healthcare’s AI Evolution

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – Within the modern western healthcare sector, artificial intelligence (AI) is being enlisted to streamline...

MSFT : 503.32 (+0.37%)
SOPH : 3.49 (-6.93%)
AVAI : 0.5700 (+0.55%)
AZN : 71.13 (-0.95%)
DOCS : 60.20 (+0.20%)
Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings?

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6.In the last reported quarter, the company’s adjusted loss of 18 cents was wider than the Zacks Consensus Estimate...

TXG : 12.80 (+1.43%)
SOPH : 3.49 (-6.93%)
TEM : 56.88 (-4.56%)
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion...

SOPH : 3.49 (-6.93%)
AZN : 71.13 (-0.95%)
Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock?

The healthcare technology space is gaining enormous investors' attention these days, thanks to the rapid advancements in artificial intelligence (AI) in this niche. Companies like Tempus AI TEM are leading...

SOPH : 3.49 (-6.93%)
IRTC : 135.94 (+0.91%)
TEM : 56.88 (-4.56%)
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two...

NVDA : 164.92 (+0.50%)
SOPH : 3.49 (-6.93%)
Tempus AI Surges 40% YTD: Are New Strategic Deals a Buy Signal?

Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb....

SOPH : 3.49 (-6.93%)
IRTC : 135.94 (+0.91%)
TEM : 56.88 (-4.56%)
Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?

Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest since its successful IPO in June 2024.  The stock had been on a strong upward...

SOPH : 3.49 (-6.93%)
IRTC : 135.94 (+0.91%)
TEM : 56.88 (-4.56%)
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone in the global...

SOPH : 3.49 (-6.93%)
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortalâ„¢...

SOPH : 3.49 (-6.93%)
Tempus AI Stock Before Q4 Earnings: To Buy or Not to Buy?

Tempus AI, Inc. TEM is likely to report fourth-quarter fiscal 2024 results shortly.See the Zacks Earnings Calendar to stay ahead of market-making news.For the fourth quarter and full-year 2024, Tempus...

TXG : 12.80 (+1.43%)
SOPH : 3.49 (-6.93%)
TEM : 56.88 (-4.56%)

Business Summary

SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights...

See More

Key Turning Points

3rd Resistance Point 3.82
2nd Resistance Point 3.76
1st Resistance Point 3.62
Last Price 3.49
1st Support Level 3.42
2nd Support Level 3.36
3rd Support Level 3.22

See More

52-Week High 4.92
Fibonacci 61.8% 4.03
Fibonacci 50% 3.75
Last Price 3.49
Fibonacci 38.2% 3.47
52-Week Low 2.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar